EUCTR2010-023507-95-IT进行中（未招募）不适用
BASICS Trial (Basilar Artery International Cooperation Study Research Protocol) - BASICS trial
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 750
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •- Symptoms and signs compatible with ischemia in the basilar artery territory and an NIHSS = 10 at time of randomization. - Basilar artery occlusion confirmed by CTA or MRA. - Age18 through 85 years - Initiation of IV rt-PA within 4.5 hours of estimated time of basilar artery occlusion.(Estimated time of basilar artery occlusion is defined as time of onset of acute symptoms leading to clinical diagnosis of basilar artery occlusion or if not known last time patient was seen normal prior to onset of these symptoms). - Initiation of IA therapy should be feasible within 6 hours of estimated time of basilar artery occlusion.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 300
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 450
排除标准
- •Pre-existing dependency with mRankin =3. • Females of childbearing potential who are known to be pregnant and/or lactating or who have positive pregnancy tests on admission. • Patients who require hemodialysis or peritoneal dialysis. • Other serious, advanced, or terminal illness. • Any other condition that the investigator feels would pose a significant hazard to the patient if IA therapy is initiated. • Current participation in another research drug treatment protocol (patient cannot start another experimental agent until after 90 days). • Informed consent is not or cannot be obtained. • Lesion consistent with hemorrhage of any degree. • Significant cerebellar mass effect or acute hydrocephalus. • Bilateral extended brainstem ischemia.
研究者
相似试验
进行中（未招募）
1 期
Basilar Artery International Cooperation StudyBasilar artery occlusionMedDRA version: 20.0 Level: PT Classification code 10063093 Term: Basilar artery thrombosis System Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0 Level: PT Classification code 10048963 Term: Basilar artery occlusion System Organ Class: 10029205 - Nervous system disordersEUCTR2010-023507-95-DEBASICS Study Group750
进行中（未招募）
1 期
PNET 5 MedulloblastomaHistologically proven medulloblastoma, including the following subtypes, as defined in the WHO classification (2007):classic medulloblastomadesmoplastic/nodular medulloblastomaMedDRA version: 20.0Level: PTClassification code 10027107Term: MedulloblastomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-004868-30-GBniversity Medical Centre Hamburg - Eppendorf360
进行中（未招募）
1 期
AN INTERNATIONAL PHASE III RANDOMISED TRIAL COMPARING THE PROPOFOL CONSUMPTION DURING GENERAL ANAESTHESIA WITH XENON IN INSPIRATORY CONCENTRATIONS OF 50 % AND 70% AND TOTAL IV ANAESTHESIA ALONE IN ASA III PATIENTS WITH STABLE CORONARY HEART DISEASE - General anaesthesia with xenogeneral anaesthesia.EUCTR2007-001979-10-FRAIR LIQUIDE240
进行中（未招募）
1 期
AN INTERNATIONAL PHASE III RANDOMISED TRIAL COMPARING THE PROPOFOL CONSUMPTION DURING GENERAL ANAESTHESIA WITH XENON IN INSPIRATORY CONCENTRATIONS OF 50 % AND 70% AND TOTAL IV ANAESTHESIA ALONE IN ASA III PATIENTS WITH INCREASED RISK OF PERIOPERATIVE CARDIAC COMPLICATIONS - General anaesthesia with xenoEUCTR2007-001979-10-DEAIR LIQUIDE144
进行中（未招募）
1 期
AN INTERNATIONAL PHASE III RANDOMISED TRIAL COMPARING THE PROPOFOL CONSUMPTION DURING GENERAL ANAESTHESIA WITH XENON IN INSPIRATORY CONCENTRATIONS OF 50 % AND 70% AND TOTAL IV ANAESTHESIA ALONE IN ASA III PATIENTS WITH INCREASED RISK OF PERIOPERATIVE CARDIAC COMPLICATIONS - General anaesthesia with xenoEUCTR2007-001979-10-GBAIR LIQUIDE144